Live from OCTANe OTS 2023

Eyeluminaries

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, are live at OCTANe OTS with Mark Leahey, Brent Saunders, Yari Mitchell and Robert Dempsey, discussing their experiences and influence across the ophthalmic space.

· Welcome to the Eyeluminaries podcast :01

· Review of episode 16 with Stephen McLeod, MD :28

· Preview of episode 17, live at Octane OTS 1:00

· Introduce Mark Leahey, president & CEO for the Medical Device Manufacturers Association 1:23

· Challenges in medical device 2:19

· Is it possible for the government to reduce regulation of medical devices while still protecting patients? 4:32

· What is MDMA doing for sustainability? 6:50

· What is one issue that device manufacturers need to implement? 9:04

· Introduce Brent Saunders, Chairman and CEO of Bausch + Lomb 12:23

· What’s different about Bausch + Lomb today that wasn’t around when you first worked for the company? 13:27

· Tell us about other products at Bausch + Lomb. 19:22

· Introducing Yari Mitchell, the president of Y Factor Consulting, Inc. 23:31

· What have been the most important changes in the ophthalmic industry over the past couple of years? 24:58

· What advice would you give to an early-career person? 26:15

· Favorite memories of Jim Mazzo 29:14

· Introducing Robert Dempsey, CEO and President of AsclepiX Therapeutics 32:10

· What was it like to leap from medical sciences to a leadership position? 33:22

· Managing a pipeline that includes both retinal and cornea treatments 35:05

· How do you establish yourself as a competitor in age-related macular degeneration research in a mature and crowded market with limited resources? 36:10

· Creating a retinal treatment delivered via the suprachoroidal route 37:28

· The Holland Foundation For Sight Restoration seeking to spread access to eye care for patients and the importance of giving back 38:27

· Feedback, questions and guest suggestions at [e-mail] 44:00

· Thanks for listening 44:19

Robert Dempsey is the CEO and president of AsclepiX Therapeutics.

John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California.

Mark Leahey is the president and CEO of the Medical Device Manufacturers Association.

Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA.

Yari Mitchell is the president of Y Factor Consulting, Inc.

Brent Saunders is the chairman and CEO of Bausch + Lomb.

We’d love to hear from you! Send your comments/questions to [e-mail]. Follow John Hovanesian on Twitter @DrHovanesian.

Disclosures: Dempsey is the president and CEO of AsclepiX Therapeutics. Hovanesian consults widely in the ophthalmic field. Leahey is the president & CEO for the Medical Device Manufacturers Association. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. Mitchell is the chief business development officer at AcuFocus and the president of Y Factor Consulting, Inc. Saunders is the chairman and CEO of Bausch + Lomb.